Mark Bustoros, MD, Weill Cornell Medicine, New York City, NY, discusses the challenges of treating patients with extramedullary myeloma, highlighting a recent study exploring the molecular differences between extramedullary disease and standard multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.